NCT01580072

Brief Summary

Evaluation whether the introduction of large-scale telemonitoring of patients with COPD produces benefits in terms of reduced hospital readmissions, improved health related quality of life and health status. In addition, the trials evaluate the economical and organizational impact of the new services and examine their acceptability by patients and health professionals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

April 17, 2012

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 18, 2012

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

July 1, 2015

Completed
Last Updated

July 23, 2015

Status Verified

April 1, 2015

Enrollment Period

3.4 years

First QC Date

April 17, 2012

Results QC Date

April 8, 2015

Last Update Submit

July 1, 2015

Conditions

Outcome Measures

Primary Outcomes (2)

  • Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.

    Baseline analyses and analyses after 12 months were conducted. Normal distribution is not given for SF-36 scales, means and Standard Deviation are reported. A high score defines a more favorable health state, items are scored on a 0 to 100 range. Scale scores represent the average for all items in the scale that the respondent answered.

    12 months

  • Number of Inpatient Stays

    12 months

Secondary Outcomes (8)

  • Number of Bed Days for Hospitalised Patients

    12 months

  • Number of Primary Care Visits

    12 months

  • Number of Specialist Visits

    12 months

  • Number of Consultations of Emergency Doctor

    12 months

  • All Cause Mortality

    12 months

  • +3 more secondary outcomes

Study Arms (3)

Control group

NO INTERVENTION

Participants in the control group receive usual care.

Self monitoring for patients with COPD

EXPERIMENTAL
Other: self-monitoring for patients with severe COPD

Nurse monitoring for patients with COPD

EXPERIMENTAL
Other: nurse-monitoring for patients with severe COPD

Interventions

Intervention Group entering vital parameters via Web Portal or automatic call center.

Self monitoring for patients with COPD

Nurses are entering vital parameters of the patient with mobile devices.

Nurse monitoring for patients with COPD

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • COPD 3 or 4
  • Be able to use the system provided
  • Life expectancy \> 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

LKH Laas

Kötschach, Carintha, 9640, Austria

Location

Klinikum Klagenfurt

Klagenfurt, Carinthia, 9020, Austria

Location

LKH Villach

Villach, Carinthia, 9500, Austria

Location

MeSH Terms

Conditions

Lung DiseasesPulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Respiratory Tract DiseasesLung Diseases, ObstructiveChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Hannes Steinberger
Organization
Landeskrankenanstalten-Betriebsgesellschaft

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 17, 2012

First Posted

April 18, 2012

Study Start

February 1, 2010

Primary Completion

July 1, 2013

Study Completion

February 1, 2014

Last Updated

July 23, 2015

Results First Posted

July 1, 2015

Record last verified: 2015-04

Locations